Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

First nationwide clinical indication-based diagnostic reference levels incorporating size-specific dose estimates for adult chest CT in Morocco.

Created on 19 Jun 2026

Authors

Youssef Madkouri, Hamza Sekkat, Oussama El Mouden, Farida Bentayeb, Youssef El Merabet, Abdellah Khallouqi, Abdellah Halimi, Omar El Rhazouani

Published in

Emergency radiology. Jun 19, 2026. Epub Jun 19, 2026.

Abstract

To establish nationwide clinical indication-based multicenter diagnostic reference levels (DRLs) for adult chest CT examinations in Morocco.
This retrospective multicenter study included 1,238 adult chest CT examinations grouped into four clinical indications: Lung nodule/follow-up, Infection/ILD/fibrosis, lung cancer staging/lymph node evaluation, and emergency/PE/trauma. For each indication, CTDIvol and dose-length product (DLP) were analyzed. Multicenter DRLs were defined as the 75th percentile of center-level median CTDIvol and DLP values. Differences between indication groups were assessed using the Kruskal-Wallis test, with results reported using medians and 95% confidence intervals.
Dose levels differed significantly between clinical indications for both CTDIvol and DLP (p < 0.001). Emergency/PE/trauma examinations showed the highest patient-level dose values, followed by lung cancer staging/lymph node evaluation, infection/ILD/fibrosis, and lung nodule/follow-up. Patient-level P75 values for CTDIvol were 10.11, 7.10, 5.00, and 4.80 mGy, respectively, while corresponding DLP P75 values were 439.78, 339.60, 250.00, and 214.60 mGy·cm.
Adult chest CT dose levels vary substantially according to clinical indication. Clinical indication-based multicenter DRLs provide a more appropriate optimization framework than a single anatomy-based chest CT DRL and should be used to guide protocol harmonization and dose optimization in Moroccan CT practice.

PMID:
42319637
Bibliographic data and abstract were imported from PubMed on 19 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement